David R. Greaves
University of Oxford · 263 works · 21,512 citations · h-index 75
Top works
- Position-independent, high-level expression of the human β-globin gene in transgenic mice
- A new class of membrane-bound chemokine with a CX3C motif
- Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
- CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells
- A dominant control region from the human β-globin locus conferring integration site-independent gene expression
- The β-globin dominant control region activates homologous and heterologous promoters in a tissue-specific manner
- Human CD2 3′-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice
- Programmed Gene Rearrangements Altering Gene Expression
- Importance of globin gene order for correct developmental expression.
- Tissue-specific targeting of gytokine unresponsiveness in transgenic mice
- Tumor Necrosis Factor-α-converting Enzyme (ADAM17) Mediates the Cleavage and Shedding of Fractalkine (CX3CL1)
- Facile cruciform formation by an (A-T)34 sequence from a Xenopus globin gene
- Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences
- TH2 Cytokines and Allergic Challenge Induce Ym1 Expression in Macrophages by a STAT6-dependent Mechanism
- Identification of Novel, Functional Genetic Variants in the Human Matrix Metalloproteinase-2 Gene
- High-level, erythroid-specific expression of the human alpha-globin gene in transgenic mice and the production of human hemoglobin in murine erythrocytes.
- (AT)n is an interspersed repeat in the Xenopus genome.
- Synthetic chemerin-derived peptides suppress inflammation through ChemR23
- The Transmembrane Form of the CX3CL1 Chemokine Fractalkine Is Expressed Predominantly by Epithelial Cells in Vivo
- Autocrine Deactivation of Macrophages in Transgenic Mice Constitutively Overexpressing IL-10 Under Control of the Human CD68 Promoter